Jardiance 25 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F7VG5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $87,318
Award facts
- Contract value 100% obligated
- $87,318.04 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $87.3K by the Defense Logistics Agency on January 20, 2026, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract carries an ultimate completion date of January 21, 2026, with performance to be fulfilled from the company's facility in Conshohocken, Pennsylvania. The award represents no set-aside designation, indicating full and open competition among qualified vendors. Jardiance is a widely prescribed medication for managing type 2 diabetes, reflecting the pharmaceutical distributor's critical role in supplying essential medications to federal healthcare systems.
This delivery order falls under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.9M vehicle running through December 2026 that serves as the primary procurement mechanism for comprehensive pharmaceutical and medical supply support to military healthcare programs worldwide. The parent company, Cencora, Inc., holds an expanded IDC with DLA valued at up to $999.9M through December 2031, underscoring the organization's significance as a primary pharmaceutical vendor for defense medical logistics. Through these contract vehicles, the company supplies a diverse portfolio of medications and medical commodities to support military treatment facilities, veterans' healthcare systems, and other federal medical institutions globally.
Quick answers
Who was awarded contract SPE2DR26F7VG5?
SPE2DR26F7VG5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F7VG5 worth?
The government has obligated $87,318 on SPE2DR26F7VG5.
Is contract SPE2DR26F7VG5 an order under another contract?
Yes. SPE2DR26F7VG5 is a delivery order under SPE2DR25D2216, an indefinite delivery contract.
Was contract SPE2DR26F7VG5 competed?
The extent of competition for SPE2DR26F7VG5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award